552 reports of this reaction
3.2% of all DOFETILIDE reports
#4 most reported adverse reaction
DIZZINESS is the #4 most commonly reported adverse reaction for DOFETILIDE, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 552 FDA adverse event reports linking DOFETILIDE to DIZZINESS. This represents approximately 3.2% of all 17,040 adverse event reports for this drug.
Patients taking DOFETILIDE who experience dizziness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIZZINESS is moderately reported among DOFETILIDE users, representing a notable but not dominant share of adverse events.
In addition to dizziness, the following adverse reactions have been reported for DOFETILIDE:
The following drugs have also been linked to dizziness in FDA adverse event reports:
DIZZINESS has been reported as an adverse event in 552 FDA reports for DOFETILIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIZZINESS accounts for approximately 3.2% of all adverse event reports for DOFETILIDE, making it a notable side effect.
If you experience dizziness while taking DOFETILIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.